Flavia Morales-Vásquez

Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial

Miguel Martín, Monserrat Muñoz, A. Balil et al. · The Lancet Oncology · 2007 · 186 citations

Medicine, Oncology, Pharmacology +16

Adjuvant Chemotherapy with Doxorubicin and Dacarbazine has No Effect in Recurrence-Free Survival of Malignant Phyllodes Tumors of the Breast

Flavia Morales-Vásquez, Ana M. González-Angulo, Kristine Broglio et al. · The Breast Journal · 2007 · 120 citations

Medicine, Oncology, Pharmacology +11

Randomized Phase II Trial of First-Line Trastuzumab Plus Docetaxel and Capecitabine Compared With Trastuzumab Plus Docetaxel in <i>HER2</i>-Positive Metastatic Breast Cancer

Andrew Wardley, Xavier Pivot, Flavia Morales-Vásquez et al. · Journal of Clinical Oncology · 2009 · 118 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Gastric cancer in young people under 30 years of age: worse prognosis, or delay in diagnosis?

Horacio Noé López-Basave, Flavia Morales-Vásquez, Ruiz Jm et al. · Cancer Management and Research · 2013 · 46 citations · Full text

Medicine, Oncology, Pathology +16

High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma

Flavia Morales-Vásquez, E. Pedernera, Jesús Reynaga-Obregón et al. · Journal of Ovarian Research · 2016 · 39 citations · Full text

Medicine, Gynecology, Oncology +17